Several studies have established FGFBP1 as an oncogenic factor within the tumor microenvironment by virtue of its activation of proliferative FGFR signaling pathways [23,24,25,26], a mechanism consistent with the well-documented pro-proliferative effects observed in various cancer models [27,28]. Here, FGFBP1 is linked to cancer.